Internal Medicine, Gastroenterology · Baltimore, MD
NPI
1720019474
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
600 N Wolfe St
Baltimore, MD, 21287
Phone (410) 955-4166
Groups this clinician bills Medicare through
Medicare paid, 2024
$90K
1,174 services
Medicare patients, 2024
526
Average age 71
Drug cost, 2024
$1.0M
1,164 prescriptions
Company payments, 2025
$29K
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Paul Thuluvath was code 99213 (office e&m - established), 214 times for 151 patients. In total Paul Thuluvath billed 1,174 services in 34 codes, and Medicare paid $90K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 214 | 151 | $69.37 | $15K |
| 99213 Office E&M - Established | Facility | 187 | 151 | $49.64 | $9,283 |
| 91200 Standard X-ray | Facility | 134 | 131 | $7.68 | $1,029 |
| 99214 Office E&M - Established | Facility | 103 | 92 | $73.68 | $7,589 |
| 99214 Office E&M - Established | Office | 90 | 79 | $98.58 | $8,872 |
| 99204 Office E&M - New | Office | 51 | 51 | $131.68 | $6,716 |
| 99204 Office E&M - New | Facility | 37 | 37 | $100.72 | $3,727 |
| 90739 Vaccine Product | Office | 27 | 21 | $161.44 | $4,359 |
| 99203 Office E&M - New | Facility | 26 | 26 | $62.08 | $1,614 |
| G0010 Administration of hepatitis b vaccine | Office | 25 | 21 | $33.53 | $838 |
| 43235 Upper GI Endoscopy | Facility | 22 | 22 | $89.52 | $1,969 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 19 | 17 | $162.28 | $3,083 |
| 99215 Office E&M - Established | Facility | 19 | 19 | $118.38 | $2,249 |
| 45380 Lower GI Endoscopy - Other | Facility | 18 | 18 | $112.34 | $2,022 |
| 43239 Upper GI Endoscopy | Facility | 16 | 16 | $82.97 | $1,327 |
By year: 2022 $115K for 1,379 services; 2023 $107K for 1,265 services; 2024 $90K for 1,174 services.
Medicare prescription drug claims, 2024
In 2024, the drug Paul Thuluvath prescribed most often to Medicare patients was Tacrolimus, with 134 prescriptions and refills. In total Paul Thuluvath wrote 1,164 Medicare prescriptions that cost $1.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tacrolimus Generic | 134 | 252 | 29 | $19K |
| Ursodiol Generic | 108 | 226 | 26 | $20K |
| Xifaxan Rifaximin | 95 | 95 | 11 | $285K |
| Azathioprine Generic | 87 | 169 | 16 | $11K |
| Omeprazole Generic | 70 | 160 | 20 | $866 |
| Prednisone Generic | 62 | 92 | 14 | $525 |
| Entecavir Generic | 38 | 84 | Under 11 | $9,023 |
| Amlodipine Besylate Generic | 38 | 98 | 11 | $666 |
| Mycophenolate Mofetil Generic | 35 | 71 | Under 11 | $1,399 |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 34 | 34 | 33 | $408 |
| Pantoprazole Sodium Generic | 30 | 72 | Under 11 | $520 |
| Furosemide Generic | 29 | 87 | 11 | $200 |
| Rezdiffra Resmetirom | 26 | 28 | Under 11 | $108K |
| Sirolimus Generic | 25 | 59 | Under 11 | $28K |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 19 | 19 | 18 | $1,214 |
Brand drugs: 222 claims; generic drugs: 942 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Paul Thuluvath $29K ($29K in general payments such as food, travel and fees) from 19 companies. The largest payer was Madrigal Pharmaceuticals with $15K.
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals MDGL | 27 | $15K |
| Gilead Sciences, Inc. GILD | 21 | $13K |
| Abbvie Inc. ABBV | 8 | $199 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 8 | $183 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 4 | $105 |
| Phathom Pharmaceuticals, Inc. PHAT | 3 | $54.69 |
| Mallinckrodt Hospital Products Inc. | 2 | $52.51 |
| Intercept Pharmaceuticals, Inc. | 2 | $43.9 |
| Novo Nordisk Inc NVO | 2 | $40.13 |
| Genzyme Corporation SNY | 1 | $26.09 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.